TickerFactsScreenerDevelopers

ATOSSA THERAPEUTICS, INC. (ATOS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$3.49M2014: -$10.56M2015: -$13.95M2016: -$5.37M2017: -$6.59M2018: -$8.96M2019: -$9.13M2020: -$11.57M2021: -$16.47M2022: -$20.76M2023: -$20.94M2024: -$21.03M2025: -$29.76M-$29.76M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$29.76M-41.5%
2024-$21.03M-0.4%
2023-$20.94M-0.9%
2022-$20.76M-26.0%
2021-$16.47M-42.4%
2020-$11.57M-26.7%
2019-$9.13M-1.9%
2018-$8.96M-35.9%
2017-$6.59M-22.7%
2016-$5.37M+61.5%
2015-$13.95M-32.2%
2014-$10.56M—
2011-$3.49M—